These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19578096)

  • 1. Cellular approaches to central nervous system remyelination stimulation: thyroid hormone to promote myelin repair via endogenous stem and precursor cells.
    Calzà L; Fernandez M; Giardino L
    J Mol Endocrinol; 2010 Jan; 44(1):13-23. PubMed ID: 19578096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cellular and molecular events of central nervous system remyelination.
    Dubois-Dalcq M; Armstrong R
    Bioessays; 1990 Dec; 12(12):569-76. PubMed ID: 2080911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease.
    Calzà L; Fernandez M; Giuliani A; D'Intino G; Pirondi S; Sivilia S; Paradisi M; Desordi N; Giardino L
    Brain Res Brain Res Rev; 2005 Apr; 48(2):339-46. PubMed ID: 15850672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular approaches for stimulating CNS remyelination.
    Miller RH; Bai L
    Regen Med; 2007 Sep; 2(5):817-29. PubMed ID: 17907933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing central nervous system remyelination in multiple sclerosis.
    Dubois-Dalcq M; Ffrench-Constant C; Franklin RJ
    Neuron; 2005 Oct; 48(1):9-12. PubMed ID: 16202704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do central nervous system axons remyelinate?
    Nait-Oumesmar B; Lachapelle F; Decker L; Baron-Van Evercooren A
    Pathol Biol (Paris); 2000 Feb; 48(1):70-9. PubMed ID: 10729914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial precursor cell transplantation therapy for neurotrauma and multiple sclerosis.
    Kulbatski I; Mothe AJ; Parr AM; Kim H; Kang CE; Bozkurt G; Tator CH
    Prog Histochem Cytochem; 2008; 43(3):123-76. PubMed ID: 18706353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding CNS remyelination: clues from developmental and regeneration biology.
    Franklin RJ; Hinks GL
    J Neurosci Res; 1999 Oct; 58(2):207-13. PubMed ID: 10502277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination.
    Franco PG; Silvestroff L; Soto EF; Pasquini JM
    Exp Neurol; 2008 Aug; 212(2):458-67. PubMed ID: 18572165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells.
    Groves AK; Barnett SC; Franklin RJ; Crang AJ; Mayer M; Blakemore WF; Noble M
    Nature; 1993 Apr; 362(6419):453-5. PubMed ID: 8464477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects of cell therapy for disorders of myelin.
    Ben-Hur T; Goldman SA
    Ann N Y Acad Sci; 2008 Oct; 1142():218-49. PubMed ID: 18990129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic use of stem cells for myelin repair in autoimmune demyelinating disorders.
    Pluchino S; Martino G
    J Neurol Sci; 2005 Jun; 233(1-2):117-9. PubMed ID: 15896808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remyelination in demyelinating diseases of the central nervous system.
    Ludwin SK
    Crit Rev Neurobiol; 1987; 3(1):1-28. PubMed ID: 3552450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triiodothyronine administration ameliorates the demyelination/remyelination ratio in a non-human primate model of multiple sclerosis by correcting tissue hypothyroidism.
    D'Intino G; Lorenzini L; Fernandez M; Taglioni A; Perretta G; Del Vecchio G; Villoslada P; Giardino L; Calzà L
    J Neuroendocrinol; 2011 Sep; 23(9):778-90. PubMed ID: 21707794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remyelination of the central nervous system: a valuable contribution from the periphery.
    Zujovic V; Bachelin C; Baron-Van Evercooren A
    Neuroscientist; 2007 Aug; 13(4):383-91. PubMed ID: 17644768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulins promote remyelination in the central nervous system.
    Rodriguez M; Lennon VA
    Ann Neurol; 1990 Jan; 27(1):12-7. PubMed ID: 2301922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The life, death, and replacement of oligodendrocytes in the adult CNS.
    McTigue DM; Tripathi RB
    J Neurochem; 2008 Oct; 107(1):1-19. PubMed ID: 18643793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions.
    Islam MS; Tatsumi K; Okuda H; Shiosaka S; Wanaka A
    Neurochem Int; 2009; 54(3-4):192-8. PubMed ID: 19070638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous stem and precursor cells for demyelinating diseases: an alternative for transplantation?
    D'Intino G; Perretta G; Taglioni A; Calistri M; Falzone C; Baroni M; Giardino L; Calzà L
    Neurol Res; 2006 Jul; 28(5):513-7. PubMed ID: 16808881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligodendrocytes: from development to demyelinated lesion repair.
    Rogister B; Belachew S; Moonen G
    Acta Neurol Belg; 1999 Mar; 99(1):32-9. PubMed ID: 10218090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.